Trachoma

Trachoma is an infectious disease of the eye caused by the microorganism Chlamydia trachomatis. It is a chronic disease characterized by inflammation of the conjunctiva and cornea, which can lead to blindness. Trachoma is a leading cause of irreversible blindness in low-income countries, particularly in the Sahel region and other parts of Africa, as well as in parts of Asia and the Middle East. Transmission occurs through direct contact with secretions from the eyes or nose of an infected person, as well as through contaminated hands and objects. The disease progresses through several stages, starting with mild redness and progressing to complications such as scarring of the conjunctiva and cornea, which can lead to severe vision loss.

History of the disease and interesting historical facts

Trachoma has been known to mankind for over two millennia. The first mentions of the disease can be found in the treatises of Hippocrates and other ancient Greek sources. An interesting historical fact is that trachoma was widespread in ancient times, when living conditions and sanitary standards were significantly lower than today. In the 20th century, the disease was considered an important public health problem, and the fight against trachoma received new impetus after World War II, when organizations such as the World Health Organization (WHO) began to take measures to eradicate it. In the 1970s, scientific analysis of trachoma treatment and prevention methods was conducted, which allowed new strategies to combat this disease to be developed.

Epidemiology

According to WHO, trachoma is still a common cause of blindness in developing countries today. Estimates show that about 135 million people live in high-risk conditions, and more than 1 billion people may be exposed to this infection. In the African region, the prevalence of trachoma is about 20%, while in some countries such as Ethiopia and Niger, this figure reaches 50%. According to studies, trachoma is also observed among people exposed to the atmosphere, as well as among populations lacking sanitation, safe water and education. In recent years, due to increased prevention and control programs, there has been a downward trend in prevalence.

Genetic predisposition to this disease

Research suggests that genetic predisposition may play a role in susceptibility to trachoma. Certain populations have genetic variations that may increase the risk of developing the disease. Modern genetic research has identified a number of genes involved in the immune response to Chlamydia trachomatis infection. For example, it has been established that polymorphisms in genes encoding cytokines such as IL-1 and IL-6 may influence the likelihood of developing trachoma. Mutations in these genes may lead to an abnormal immune response, which in turn provokes a more severe course of the disease.

Risk factors for the development of this disease

There are various risk factors that contribute to the development of trachoma. These include:

• Poor sanitation: lack of clean water and proper sanitation.
• Population density: crowding of people under unfavorable conditions.
• Health problems: presence of other diseases, such as HIV, which reduce immunity.
• Climate conditions: high temperature and dryness, which promote the spread of infection.
• Polorhythm: Women tend to have a higher risk of the disease due to their proximity to children and frequent care of them.

These factors increase susceptibility to trachoma, necessitating the development of public health programs to eliminate them.

Diagnosis of this disease

Diagnosis of trachoma is based on clinical signs, as well as laboratory and instrumental research methods. The main symptoms include:

• Redness and inflammation of the conjunctiva.
• Tearing and discomfort in the eye.
• The appearance of ciliary syndrome: curvature of the eyelids, leading to corneal trauma.

Laboratory tests include microscopic examination of eye discharge to identify microorganisms. Radiological tests, such as ocular ultrasound, may be used to evaluate internal changes. Differential diagnosis includes ruling out other infectious and non-infectious eye diseases, such as conjunctivitis, keratitis, or allergic reactions.

Treatment

Treatment of trachoma includes pharmacological and surgical methods. In the initial stages, the main treatment is antibiotics, such as azithromycin and doxycycline, which help eliminate the infection. In the later stages, when scarring and complications develop, surgical intervention may be required to correct eyelid deformities and restore the normal state of the cornea.

Other treatments may include the use of anti-inflammatory drugs and topical medications to reduce symptoms. The importance of preventive measures, such as improved sanitation and education, should also be considered, which can significantly reduce the risk of re-infection.

List of medications used to treat this disease

• Azithromycin.
• Doxycycline.
• Tetracycline.
• Moxifloxacin.
• Anti-inflammatory eye drops.

These drugs are used depending on the stage of the disease and the presence of concomitant infections.

Disease monitoring

Trachoma monitoring includes regular eye examinations to assess the condition of the eyes and monitor the progress of the disease. The prognosis depends on timely diagnosis and treatment. It is important to note that advanced forms of trachoma can lead to irreversible complications, including blindness.

Complications of trachoma may include:

• Corneal scarring.
• Corneal injuries.
• Increased intraocular pressure.
• Difficulty with vision.

Thus, the importance of early detection and treatment of trachoma cannot be overestimated.

Age-related features of the disease

Trachoma can occur at any age, but children and the elderly are at increased risk. In children, the disease is most often asymptomatic, but it is at this age that the risk of transmission of the infection increases significantly. In the elderly, trachoma usually manifests itself with more pronounced symptoms, which is associated with changes in the immune system.

Questions and Answers

• What is trachoma? Trachoma is an infectious eye disease caused by Chlamydia trachomatis that results in inflammation of the conjunctiva and potential blindness.
• How is trachoma diagnosed? Diagnosis of trachoma is based on clinical symptoms, laboratory tests and instrumental research methods.
• How is trachoma treated? Treatment of trachoma includes antibiotic therapy in the early stages and surgical methods in the later stages to correct eyelid deformities.
• Who is at risk for trachoma? Those at risk include people with poor sanitation, women caring for children, and residents of densely populated areas.
• What is the prognosis for trachoma treatment? The prognosis depends on the stage of the disease; early diagnosis and treatment significantly improve the chances of recovery.